Review



monoclonal mouse anti human c5b 9 antibody  (Hycult Biotech)


Bioz Verified Symbol Hycult Biotech is a verified supplier
Bioz Manufacturer Symbol Hycult Biotech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Hycult Biotech monoclonal mouse anti human c5b 9 antibody
    <t>C5b-9</t> deposition and the effect of complement attack on the cell membrane integrity of S . Enteritidis PCM 2817 WT and mutant strains. A Mean fluorescence intensity (MFI) of C5b-9 neo-epitope deposition on bacterial cells. B Frequency of 7AAD positive cells; the percentage of 7AAD positive cells stands for the percentage of cells with compromised membrane integrity. The experiment was performed in three biological replicates. Data was analyzed by ordinary one-way ANOVA and Dunnett's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), assuming WT as the control group. Average from six measurements ± SD
    Monoclonal Mouse Anti Human C5b 9 Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal mouse anti human c5b 9 antibody/product/Hycult Biotech
    Average 86 stars, based on 1 article reviews
    monoclonal mouse anti human c5b 9 antibody - by Bioz Stars, 2025-07
    86/100 stars

    Images

    1) Product Images from "Lipopolysaccharide with long O-antigen is crucial for Salmonella Enteritidis to evade complement activity and to facilitate bacterial survival in vivo in the Galleria mellonella infection model"

    Article Title: Lipopolysaccharide with long O-antigen is crucial for Salmonella Enteritidis to evade complement activity and to facilitate bacterial survival in vivo in the Galleria mellonella infection model

    Journal: Medical Microbiology and Immunology

    doi: 10.1007/s00430-024-00790-3

    C5b-9 deposition and the effect of complement attack on the cell membrane integrity of S . Enteritidis PCM 2817 WT and mutant strains. A Mean fluorescence intensity (MFI) of C5b-9 neo-epitope deposition on bacterial cells. B Frequency of 7AAD positive cells; the percentage of 7AAD positive cells stands for the percentage of cells with compromised membrane integrity. The experiment was performed in three biological replicates. Data was analyzed by ordinary one-way ANOVA and Dunnett's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), assuming WT as the control group. Average from six measurements ± SD
    Figure Legend Snippet: C5b-9 deposition and the effect of complement attack on the cell membrane integrity of S . Enteritidis PCM 2817 WT and mutant strains. A Mean fluorescence intensity (MFI) of C5b-9 neo-epitope deposition on bacterial cells. B Frequency of 7AAD positive cells; the percentage of 7AAD positive cells stands for the percentage of cells with compromised membrane integrity. The experiment was performed in three biological replicates. Data was analyzed by ordinary one-way ANOVA and Dunnett's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), assuming WT as the control group. Average from six measurements ± SD

    Techniques Used: Membrane, Mutagenesis, Fluorescence, Control



    Similar Products

    86
    Danaher Inc mouse anti human c5b 9
    Mouse Anti Human C5b 9, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human c5b 9/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    mouse anti human c5b 9 - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology b 9 santa cruz biotechnology c5b monoclonal mouse human
    B 9 Santa Cruz Biotechnology C5b Monoclonal Mouse Human, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b 9 santa cruz biotechnology c5b monoclonal mouse human/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    b 9 santa cruz biotechnology c5b monoclonal mouse human - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology monoclonal mouse anti human c5b 9
    Monoclonal Mouse Anti Human C5b 9, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal mouse anti human c5b 9/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    monoclonal mouse anti human c5b 9 - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Agilent technologies monoclonal mouse anti human c5b 9
    Monoclonal Mouse Anti Human C5b 9, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal mouse anti human c5b 9/product/Agilent technologies
    Average 86 stars, based on 1 article reviews
    monoclonal mouse anti human c5b 9 - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology mouse anti human c5b 9 antibody
    Mouse Anti Human C5b 9 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human c5b 9 antibody/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    mouse anti human c5b 9 antibody - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology mouse anti human c5b 9 antibody conjugated with peroxidase
    Mouse Anti Human C5b 9 Antibody Conjugated With Peroxidase, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human c5b 9 antibody conjugated with peroxidase/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    mouse anti human c5b 9 antibody conjugated with peroxidase - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Hycult Biotech monoclonal mouse anti human c5b 9 antibody
    <t>C5b-9</t> deposition and the effect of complement attack on the cell membrane integrity of S . Enteritidis PCM 2817 WT and mutant strains. A Mean fluorescence intensity (MFI) of C5b-9 neo-epitope deposition on bacterial cells. B Frequency of 7AAD positive cells; the percentage of 7AAD positive cells stands for the percentage of cells with compromised membrane integrity. The experiment was performed in three biological replicates. Data was analyzed by ordinary one-way ANOVA and Dunnett's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), assuming WT as the control group. Average from six measurements ± SD
    Monoclonal Mouse Anti Human C5b 9 Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal mouse anti human c5b 9 antibody/product/Hycult Biotech
    Average 86 stars, based on 1 article reviews
    monoclonal mouse anti human c5b 9 antibody - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Agilent technologies mouse anti human c5b 9
    Targeted bispecific antibodies that bind endogenous complement inhibitors decrease complement activation in situ. BsAbs were functionally tested in plate-bound complement activation assays. Plates coated with BSA-DNP and IgG (classical pathway), acetylated HSA (lectin pathway), or LPS (alternative pathway) were incubated with a titration of anti-FH x anti-DNP (A, C) , 5 µg/mL anti-FH x anti-DNP (B, D) , a titration of anti-C4BP x anti-DNP (E, G) , or 5 µg/mL anti-C4BP x anti-DNP (F, H) or control bsAbs, with NHS with (+) or without (-) exogenous FH (A–D) or C4BP (E–H) . FH (A, B) , C4BP (E, F) , and <t>C5b-9</t> (C, D, G, H) were detected. In (A, C, E, G) IgG-coated plates were used. Bars indicate means and error bars indicate standard deviations of one representative experiment out of at least three experiments. One-way ANOVA compared to no bsAb, **P < 0.01; ***P < 0.001; ****P < 0.0001.
    Mouse Anti Human C5b 9, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human c5b 9/product/Agilent technologies
    Average 86 stars, based on 1 article reviews
    mouse anti human c5b 9 - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    C5b-9 deposition and the effect of complement attack on the cell membrane integrity of S . Enteritidis PCM 2817 WT and mutant strains. A Mean fluorescence intensity (MFI) of C5b-9 neo-epitope deposition on bacterial cells. B Frequency of 7AAD positive cells; the percentage of 7AAD positive cells stands for the percentage of cells with compromised membrane integrity. The experiment was performed in three biological replicates. Data was analyzed by ordinary one-way ANOVA and Dunnett's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), assuming WT as the control group. Average from six measurements ± SD

    Journal: Medical Microbiology and Immunology

    Article Title: Lipopolysaccharide with long O-antigen is crucial for Salmonella Enteritidis to evade complement activity and to facilitate bacterial survival in vivo in the Galleria mellonella infection model

    doi: 10.1007/s00430-024-00790-3

    Figure Lengend Snippet: C5b-9 deposition and the effect of complement attack on the cell membrane integrity of S . Enteritidis PCM 2817 WT and mutant strains. A Mean fluorescence intensity (MFI) of C5b-9 neo-epitope deposition on bacterial cells. B Frequency of 7AAD positive cells; the percentage of 7AAD positive cells stands for the percentage of cells with compromised membrane integrity. The experiment was performed in three biological replicates. Data was analyzed by ordinary one-way ANOVA and Dunnett's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001), assuming WT as the control group. Average from six measurements ± SD

    Article Snippet: Cells were incubated with the monoclonal mouse anti-human C5b-9 antibody (clone aE11) (Hycult) for 45 min at ambient temperature, washed and detected with an anti-mouse Alexa 488 antibody (Abcam) (45 min, ambient temperature).

    Techniques: Membrane, Mutagenesis, Fluorescence, Control

    Targeted bispecific antibodies that bind endogenous complement inhibitors decrease complement activation in situ. BsAbs were functionally tested in plate-bound complement activation assays. Plates coated with BSA-DNP and IgG (classical pathway), acetylated HSA (lectin pathway), or LPS (alternative pathway) were incubated with a titration of anti-FH x anti-DNP (A, C) , 5 µg/mL anti-FH x anti-DNP (B, D) , a titration of anti-C4BP x anti-DNP (E, G) , or 5 µg/mL anti-C4BP x anti-DNP (F, H) or control bsAbs, with NHS with (+) or without (-) exogenous FH (A–D) or C4BP (E–H) . FH (A, B) , C4BP (E, F) , and C5b-9 (C, D, G, H) were detected. In (A, C, E, G) IgG-coated plates were used. Bars indicate means and error bars indicate standard deviations of one representative experiment out of at least three experiments. One-way ANOVA compared to no bsAb, **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators

    doi: 10.3389/fimmu.2024.1288597

    Figure Lengend Snippet: Targeted bispecific antibodies that bind endogenous complement inhibitors decrease complement activation in situ. BsAbs were functionally tested in plate-bound complement activation assays. Plates coated with BSA-DNP and IgG (classical pathway), acetylated HSA (lectin pathway), or LPS (alternative pathway) were incubated with a titration of anti-FH x anti-DNP (A, C) , 5 µg/mL anti-FH x anti-DNP (B, D) , a titration of anti-C4BP x anti-DNP (E, G) , or 5 µg/mL anti-C4BP x anti-DNP (F, H) or control bsAbs, with NHS with (+) or without (-) exogenous FH (A–D) or C4BP (E–H) . FH (A, B) , C4BP (E, F) , and C5b-9 (C, D, G, H) were detected. In (A, C, E, G) IgG-coated plates were used. Bars indicate means and error bars indicate standard deviations of one representative experiment out of at least three experiments. One-way ANOVA compared to no bsAb, **P < 0.01; ***P < 0.001; ****P < 0.0001.

    Article Snippet: Next, FH and C4BP were detected as described above for the bispecificity ELISA (using either goat anti-human FH and HRP-labeled rabbit anti-goat Ig, or using rabbit anti-human C4BP and HRP-labeled goat anti-rabbit Ig), and C5b-9 was detected using mouse anti-human C5b-9 (Dako, M0777) and HRP-labeled goat anti-mouse Ig (Dako, P0447), all diluted in PTB buffer.

    Techniques: Activation Assay, In Situ, Incubation, Titration, Control